HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON (HORIZON)
Sponsor: HLT Inc.
A NA clinical study on Aortic Valve Stenosis and Severe Aortic Stenosis, this trial is completed. The trial is conducted by HLT Inc. and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
-
Apr 2021 — May 2021 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2019 — Aug 2020 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Aug 2019 [monthly]
Active Not Recruiting NA
Status: Terminated → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- HLT Inc.
For direct contact, visit the study record on ClinicalTrials.gov .